logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (vii) All inpatient clients, age distribution by primary drug (%)

Substance<1515-1920-2425-2930-3435-3940-4445+Mean ageAge knownAge not known
Opioids0.03.415.525.823.414.59.18.332.01780312
Cocaine0.02.715.224.622.316.010.98.332.523321
Stimulants0.210.027.424.515.58.75.88.029.2468912
Hypnotics and sedatives0.12.111.513.113.311.310.737.937.719652
Hallucinogens0.06.132.624.322.18.33.92.828.31810
Volatile substances6.345.518.512.48.04.92.22.222.84112
Cannabis 0.516.832.222.112.97.04.14.327.058560
Other substances 0.26.721.821.617.510.98.912.431.536081
Total0.27.120.223.719.412.08.09.531.03684530
 

Notes

The countries supplying data are:

AT; BE; BG; HR; CY; CZ; DK; FI; FR; DE; GR; HU; IE; NL; PL; RO; SK; SE; TR; UK.

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI outpatient and inpatient treatment centres.

Page last updated: Monday, 09 July 2012